Medical Equipment

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Forecast To Reach $7 Billion By 2030 At 18.1% CAGR

April 9, 2026April 9, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market From 2026 To 2030?

The market size for artificial intelligence (ai) in in vitro diagnostics (ivd) has seen considerable expansion in recent times. It is anticipated to expand from $3.04 billion in 2025 to reach $3.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.4%. This market’s past growth can be attributed to several factors including an increased need for accurate diagnostic tools, the development of laboratory infrastructure, the growing occurrence of chronic illnesses, the integration of digital diagnostic instruments, and breakthroughs in biomarker research.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market is anticipated to show significant expansion in the coming years. Its value is projected to reach $7.01 billion by 2030, driven by a compound annual growth rate (CAGR) of 18.1%. This expansion during the forecast period is largely due to factors such as the broadening of cloud-based diagnostic platforms, the incorporation of AI with genomics, advancements in point-of-care AI diagnostics, increased capital in personalized medicine, and a rising requirement for quick and economical testing. Noteworthy trends for the forecast period include AI-enabled laboratory automation, predictive disease diagnostics, data-driven test interpretation, cloud-based diagnostic platforms, and personalized patient profiling.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Which Key Factors Are Driving The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth?

The escalating need for personalized medicine is anticipated to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market moving ahead. Personalized medicine signifies a healthcare approach that tailors prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. This field is expanding due to advancements in genomic data and sequencing technologies, which facilitate more accurate, targeted, and effective treatments customized for each patient. Artificial intelligence (AI) in in vitro diagnostics (IVD) aids personalized medicine by analyzing intricate diagnostic data to pinpoint patient-specific disease patterns, thereby enabling precise, timely, and individualized treatment choices. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a rise from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the growing demand for personalized medicine is propelling the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.

What Are The Key Segment Divisions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segment Structure?

The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning

3) By Deployment Model: Cloud-Based, On-Premise, Hybrid

4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:

1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems

2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices

3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

Which Trends Are Guiding The Direction Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Leading firms within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are prioritizing the creation of sophisticated solutions, including CE-IVDR-certified transparent AI platforms, with the goal of improving diagnostic precision, optimizing operational processes, and aiding individualized patient treatment. Such a platform refers to an AI system designed for in vitro diagnostics, which adheres to EU regulatory criteria and offers decision-making processes that are transparent, verifiable, and easy to comprehend. As an illustration, in May 2025, Diagnostics.ai, a diagnostic testing firm based in the UK, introduced PCR.AI, an intelligent offering intended to speed up and improve PCR diagnostics. This solution automates and quickens the analysis of real-time PCR diagnostics, boasting an accuracy of over 99.9%. It provides transparency by explicitly demonstrating the derivation of each result, thereby guaranteeing regulatory adherence and increasing clinical confidence. Ultimately, this substantially improves laboratory effectiveness, minimizes inaccuracies, and facilitates effortless regulatory conformity for molecular diagnostics.

Which Organizations Are Engaged In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj

Get The Full Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Region Accounts For The Largest Portion Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company

Artificial Intelligence In The Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-the-diagnostic-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info